The event has passed.
Get your ticket now! Enjoy 30% OFF with code: NETPHARMAMICRO30
(*Promotion valid until March 16th)
Keynote Speakers:
- Vanessa Figueroa Chief Executive Microbiologist and Independent Consultant at VVF Science.
- Ségolène Lebrun Expert in Microbiology and Contamination Control Sterilez
- Anders Widov Critical Utility Specialist specialized on design of water distribution systems.
SESSION I – March 25
09:00 | Reception & Accommodation
10:00 | Seminar opening
- Overview Net-Pharma Hub and meeting objectives
- Adolfo López ISPE Spain
10:30 | CCS Block 1 – Ségolène Lebrun
- Introduction regulatory framework and expectations of the authorities
From the emergence of the CCS concept to its entry into force with the latest version of Annex 1, requirements have evolved, and manufacturers have had to interpret, adapt, and above all propose solutions to respond to a new but constructive concept. What are the real expectations surrounding this concept, what do the other regulatory texts bring to the table, and what are the authorities’ concrete expectations with regard to this document that structures our quality management system?
COFFEE BREAK
12:30 | CCS Block 2 – Ségolène Lebrun
- CCS – Architecture and construction – Implementation of environmental monitoring requirements
Scope of CCS, key technical pillars, link between CCS and risk management, identification of contamination sources, translation of risk into control measures, residual risks and monitoring, how to respond to the numerous requirements set out in writing through a document or system? How does CCS impact environmental monitoring and how can you integrate the response to these requirements into your documentation? Working and discussion session: faced with the specific requirements of environmentalmonitoring and CCS, how can you integrate the responses to these requirements into yourquality management system?
LUNCH
15:00 | EM Block 1 – Vanessa Figueroa
- Why We Are Slow To Modernize Environmental Monitoring
Rapid viable methods, biofluorescent particle counters, continuous monitoring, and integrated EM platforms are no longer futuristic, yet adoption throughout the industry remains cautious. This session looks at what is truly holding organizations back, from validation strategy and data interpretation to risk tolerance and operational disruption, and discusses how to introduce new technologies without creating compliance exposure.
COFFE BREAK
17:00 | EM Block 2 – Vanessa Figueroa
- Using Environmental Monitoring Data to Evaluate Control Effectiveness
Environmental monitoring itself is not a control, it is evidence. This session explores how EM data can reveal whether contamination controls are actually working as intended. We will examine governance, accountability, trending design, alert and action management, and lifecycle review, with a focus on turning EM results into meaningful, risk-based decisions.
18:30 | End of Day 1
NETWORKING & COCKTAIL
SESSION II – March 26
09:30 | Reception and Accreditation
10:00 | CCS Block 3 – Ségolène Lebrun
- Making the CCS operational – implementing data and trends – how to bring the CCS in alife cycle
How can a concept and regulatory requirements be made operational? The results and trends collected from environmental monitoring can be used for the CCS management review. Beyond simply generating data and interpreting it technically, how can CCS be made dynamicand concrete, rather than something to be endured? The implementation of a CCS life cycle seems to be the strong operational response to the existing risk of creating a dusty and unworkable document.
COFFEE BREAK
12:00 | EM Block 3 – Vanessa Figueroa
- Microbiology as a Strategic Asset in Manufacturing
Microbiology should not sit in the background as a compliance function. When leveraged intentionally, it strengthens contamination prevention, supports operational resilience, and improves inspection readiness. This session connects microbiological capability to business performance and provides practical guidance that leaders can use to communicate its value at all leadership levels.
13:30 | OMBA – Anders Widow
- Techniques for RMM:
Current status, pros and cons, use as IPC or QC, CAPEX/OPEX, succesful deployement strategies
LUNCH
15:30 | Customer Case
17:00 | Round Table Discussion
18:00 | End of Workshop
PARTNERS:
Pago del evento
Detalles del evento
Organiza
Programa
Añadir al calendario
More Events
Get your ticket now! Enjoy 30% OFF with code: NETPHARMAMICRO30
(*Promotion valid until March 16th)
Keynote Speakers:
- Vanessa Figueroa Chief Executive Microbiologist and Independent Consultant at VVF Science.
- Ségolène Lebrun Expert in Microbiology and Contamination Control Sterilez
- Anders Widov Critical Utility Specialist specialized on design of water distribution systems.
SESSION I – March 25
09:00 | Reception & Accommodation
10:00 | Seminar opening
- Overview Net-Pharma Hub and meeting objectives
- Adolfo López ISPE Spain
10:30 | CCS Block 1 – Ségolène Lebrun
- Introduction regulatory framework and expectations of the authorities
From the emergence of the CCS concept to its entry into force with the latest version of Annex 1, requirements have evolved, and manufacturers have had to interpret, adapt, and above all propose solutions to respond to a new but constructive concept. What are the real expectations surrounding this concept, what do the other regulatory texts bring to the table, and what are the authorities’ concrete expectations with regard to this document that structures our quality management system?
COFFEE BREAK
12:30 | CCS Block 2 – Ségolène Lebrun
- CCS – Architecture and construction – Implementation of environmental monitoring requirements
Scope of CCS, key technical pillars, link between CCS and risk management, identification of contamination sources, translation of risk into control measures, residual risks and monitoring, how to respond to the numerous requirements set out in writing through a document or system? How does CCS impact environmental monitoring and how can you integrate the response to these requirements into your documentation? Working and discussion session: faced with the specific requirements of environmentalmonitoring and CCS, how can you integrate the responses to these requirements into yourquality management system?
LUNCH
15:00 | EM Block 1 – Vanessa Figueroa
- Why We Are Slow To Modernize Environmental Monitoring
Rapid viable methods, biofluorescent particle counters, continuous monitoring, and integrated EM platforms are no longer futuristic, yet adoption throughout the industry remains cautious. This session looks at what is truly holding organizations back, from validation strategy and data interpretation to risk tolerance and operational disruption, and discusses how to introduce new technologies without creating compliance exposure.
COFFE BREAK
17:00 | EM Block 2 – Vanessa Figueroa
- Using Environmental Monitoring Data to Evaluate Control Effectiveness
Environmental monitoring itself is not a control, it is evidence. This session explores how EM data can reveal whether contamination controls are actually working as intended. We will examine governance, accountability, trending design, alert and action management, and lifecycle review, with a focus on turning EM results into meaningful, risk-based decisions.
18:30 | End of Day 1
NETWORKING & COCKTAIL
SESSION II – March 26
09:30 | Reception and Accreditation
10:00 | CCS Block 3 – Ségolène Lebrun
- Making the CCS operational – implementing data and trends – how to bring the CCS in alife cycle
How can a concept and regulatory requirements be made operational? The results and trends collected from environmental monitoring can be used for the CCS management review. Beyond simply generating data and interpreting it technically, how can CCS be made dynamicand concrete, rather than something to be endured? The implementation of a CCS life cycle seems to be the strong operational response to the existing risk of creating a dusty and unworkable document.
COFFEE BREAK
12:00 | EM Block 3 – Vanessa Figueroa
- Microbiology as a Strategic Asset in Manufacturing
Microbiology should not sit in the background as a compliance function. When leveraged intentionally, it strengthens contamination prevention, supports operational resilience, and improves inspection readiness. This session connects microbiological capability to business performance and provides practical guidance that leaders can use to communicate its value at all leadership levels.
13:30 | OMBA – Anders Widow
- Techniques for RMM:
Current status, pros and cons, use as IPC or QC, CAPEX/OPEX, succesful deployement strategies
LUNCH
15:30 | Customer Case
17:00 | Round Table Discussion
18:00 | End of Workshop
PARTNERS:
